Novel Humanized Recombinant T Cell Receptor Ligands Protect the Female Brain After Experimental Stroke

Translational Stroke Research

Volumn 5, Issue 5, 2014, Pages 577-585

  Pan, Jie ^a,b   Palmateer, Julie ^b   Schallert, Timothy ^b   Hart, Madison ^b   Pandya, Arushi ^b   Vandenbark, Arthur A ^c   Offner, Halina ^c,d   Hurn, Patricia D ^b,e  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Cerebral ischemia; Gender; Immunotherapy; Partial MHC class II constructs; Sex; Stroke; Ultrasonic vocalization

Indexed keywords

HLA DR2 ANTIGEN; RECOMBINANT RECEPTOR; RECOMBINANT T LYMPHOCYTE RECEPTOR LIGAND 1000; UNCLASSIFIED DRUG; HLA DR ANTIGEN; HYBRID PROTEIN; LIGAND; LYMPHOCYTE ANTIGEN RECEPTOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN (35-55); NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT; RTL1000 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL RESEARCH; BRAIN HISTOLOGY; BRAIN INFARCTION SIZE; BRAIN PROTECTION; CONTROLLED STUDY; EXPERIMENTAL STROKE; FEMALE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SEX DIFFERENCE; SPEECH DISORDER; VOCALIZATION; ANIMAL; BRAIN; BRAIN ISCHEMIA; CONVALESCENCE; DISEASE MODEL; HUMAN; METABOLISM; PATHOLOGY; STROKE;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; FEMALE; HLA-DR ANTIGENS; HUMANS; LIGANDS; MICE; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS; RECOVERY OF FUNCTION; SEX FACTORS; STROKE; VOCALIZATION, ANIMAL;

EID: 84905564195     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-014-0345-y     Document Type: Article

References (40)

1. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2012;17: 796-808.
2. Macrez R, Ali C, Toutirais O, Le Mauff B, Defer G, Dirnagl U, et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10(5): 471-80.
3. Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience. 2009;158(3): 1098-111.
4. Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, Hurn PD, et al. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci. 2011;31(23): 8556-63.
5. Ren X, Akiyoshi K, Grafe MR, Vandenbark AA, Hurn PD, Herson PS, et al. Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity. Metab Brain Dis. 2011;27(1): 7-15.
6. Banerjee A, Wang J, Bodhankar S, Vandenbark AA, Murphy SJ, Offner H. Phenotypic changes in immune cell subsets reflect increased infarct volume in male vs female mice. Transl Stroke Res. 2013;4(5): 554-63.
7. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2006;26(5): 654-65.
8. Sahota P, Vahidy F, Nguyen C, Bui TT, Yang B, Parsha K, et al. Changes in spleen in patients with acute ischemic stroke: a pilot observational study. Int J Stroke. 2013;8(2): 60-7.
9. Burrows GG, Adlard KL, Bebo BF, Chang JW, Tenditnyy K, Vandenbark AA, et al. Regulation of encephalitogenic T cells with recombinant TCR ligand. J Immunol. 2000;164: 6366-71.
10. Burrows GG, Chou YK, Wang C, Chang JW, Finn TP, Culbertson NE, et al. Rudimentary TCR signaling triggers default IL-10 secretion by human Th1 cells. J Immunol. 2001;167: 4386-95.
11. Yadav V, Bourdette DN, Bowen JD, Lynch SG, Mattson D, Preiningerova J, et al. Recombinant T-cell receptor ligand (RTL) for treatment of multiple sclerosis: a double blind, placebo-controlled, phase 1, dose-escalation study. Autoimmun Dis. 2012;2012: 1-11.
12. Offner H, Sinha S, Burrows GG, Ferro AJ, Vandenbark AA. RTL therapy for multiple sclerosis: a phase 1 clinical study. J Neuroimmunol. 2011;231: 7-14.
13. Subramanian S, Zhang B, Kosaka Y, Burrows G, Grafe M, Vandenbark A, et al. Recombinant T cell receptor ligand treats experimental stroke. Stroke. 2009;40: 2539-45.
14. Dziennis S, Mader S, Akiyoshi K, Ren X, Ayala P, Burrows GG, et al. Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. Metab Brain Dis. 2011;26(2): 123-33.
15. Akiyoshi K, Dziennis S, Palmateer J, Ren X, Vandenbark A, Offner H, et al. Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia. Transl Stroke Res. 2011;2(3): 404-10.
16. Vandenbark AA, Meza-Romero R, Benedek G, Andrew S, Huan J, Chou YK, et al. A novel regulatory pathway for autoimmune disease: binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance. J Autoimmun. 2013;40: 96-110.
17. Benedek G, Meza-Romero R, Andrew S, Leng L, Burrows GG, Bourdette D, et al. Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects. Eur J Immunol. 2013;43: 1309-21.
18. Meza-Romero R, Benedek G, Yu X, Mooney J, Dahan R, Duvshani N, Bucala R, Offner H, Reiter Y, Burrows GG, Vandenbark AA. HLA-DRa1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis. J Immunol. 2014;192(9): 4164-73.
19. Benedek G, Zhu W, Libal N, Casper A, Yu X, Meza-Romero R, Vandenbark AA, Alkayed NJ, Offner H. A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke. Met Brain Dis 2014;29: 37-45.
20. Herson PS, Palmateer J, Hurn PD. Biological sex mechanisms of ischemic brain injury. Transl Stroke Res. 2013;4(1): 413-9.
21. Cheng J, Hurn PD. Sex shapes experimental ischemic brain injury. Steroids. 2010;75(11): 754-9.
22. Manwani B, Liu F, Scranton V, Hammond MD, Sansing LH, McCullough LD. Differential effects of aging and sex on stroke induced inflammation across the lifespan. Exp Neurol. 2013;249: 120-31.
23. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD. Gender-linked brain injury in experimental stroke. Stroke. 1998;29: 159-65.
24. McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD. Ischemic NO and PARP activation in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab. 2005;25(4): 502-12.
25. Zhang L, Schallert T, Zhang ZG, Jiang Q, Arniego P, Li Q, et al. A test for detecting long-term sensorimotor dysfunction in the mouse after focal ischemia. J Neurosci Methods. 2002;117: 207-14.
26. Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology. 2000;39: 777-87.
27. Spinetta MJ, Woodlee MT, Feinberg LM, Stroud C, Schallert K, McCormick LK, et al. Alcohol induced retrograde memory impairment in rats: prevention by caffeine. Psychopharmacology. 2008;201: 361-71.
28. Inacio AR, Bucala R, Deierborg T. Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory/immune response during the first week after stroke. J Neuroinflammation. 2011;8: 75.
29. Inacio AR, Ruscher K, Leng L, Bucala R, Deierborg T. Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke. J Cereb Blood Flow Metab. 2011;31(4): 1093-106.
30. Turtzo LC, Li J, Persky R, Benashski S, Weston G, Bucala R, et al. Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice. Neurobiol Dis. 2013;54: 421-31.
31. Wang C, Gold BG, Kaler LJ, Yu X, Afentoulis ME, Burrows GG, et al. Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE. J Neurochem. 2006;98: 1817-27.
32. Adamus G, Brown L, Andrew S, Meza-Romero R, Burrows GG, Vandenbark AA. Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice. Invest Ophthalmol Vis Sci. 2012;53: 406-12.
33. Adamus G, Wang S, Kyger M, Worley A, Lu B, Burrows GG. Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeions rats. Mol Vis. 2012;18: 2323-37.
34. Fan H, Hall P, Santos LL, Gregory JL, Fingerle-Rowson G, Bucala R, et al. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase. J Immunol. 2011;186(8): 4915-24.
35. Bowers JM, Perez-pouchoulen M, Edwards NS, McCarthy MM. Fox P2 mediates sex differences in ultrasonic vocalization by rat pups and directs order of maternal retrieval. J Neurosci. 2013;33(8): 3276-83.
36. Gaub S, Groszer M, Fisher SE, Ehret G. The structure of innate vocalizations in Foxp2-deficient mouse pups. Genes Brain Behav. 2010;9: 390-401.
37. Ciucci MR, Ma ST, Fox C, Kane JR, Ramig LO, Schallert T. Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study. Behav Brain Res. 2007;182: 284-9.
38. Simola N, Ma ST, Schallert T. Influence of acute caffeine on 50-kHZ ultrasonic vocalizations in male adult rats and relevance to caffeine-mediated psychopharmacological effects. Int J Neuropsychopharmacol. 2010;13(1): 123-32.
39. Ahrens AM, Ma ST, Duvauchelle CL, Schallert T. Repeated intravenous amphetamine exposure: rapid and persistent sensitization of 50 kHz ultrasonic trills in rats. Behav Brain Res. 2009;197(1): 205-9.
40. Shu W, Cho JY, Jiang Y, Zhang M, Weisz D, Elder GA, et al. Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene. PNAS. 2005;102(27): 9643-8.